{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:00:27Z","timestamp":1780304427916,"version":"3.54.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bone.2025.117652","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:12:31Z","timestamp":1758085951000},"page":"117652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Chronic kidney disease- mineral and bone disorder in autosomal dominant policystic kidney disease"],"prefix":"10.1016","volume":"201","author":[{"given":"S.","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Tartaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Mastroluca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Men\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rotondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bone.2025.117652_bb0005","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2215\/CJN.02320220","article-title":"Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies","volume":"16","author":"Lanktree","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2025.117652_bb0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cellsig.2018.10.003","article-title":"Role of calcium in adult onset polycystic kidney disease","volume":"53","author":"Yanda","year":"2019","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.bone.2025.117652_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.bone.2025.117652_bb0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1681\/ASN.2013040398","article-title":"Strategies targeting cAMP signaling in the treatment of polycystic kidney disease","volume":"25","author":"Torres","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.bone.2025.117652_bb0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41581-018-0108-1","article-title":"Progress in the understanding of polycystic kidney disease","volume":"15","author":"Torres","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"7596","key":"10.1016\/j.bone.2025.117652_bb0030","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature17426","article-title":"Primary cilia are not calcium-responsive mechanosensors","volume":"531","author":"Delling","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bone.2025.117652_bb0035","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1152\/physrev.00006.2016","article-title":"The Inositol Trisphosphate\/Calcium Signaling Pathway in Health and Disease","volume":"96","author":"Berridge","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bone.2025.117652_bb0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cellsig.2018.10.003","article-title":"Role of calcium in adult onset polycystic kidney disease","volume":"53","author":"Yanda","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bone.2025.117652_bb0045","doi-asserted-by":"crossref","first-page":"16704","DOI":"10.1073\/pnas.0608358103","article-title":"Coupling of STIM1 to store-operated Ca2+ entry through its constitutive and inducible movement in the endoplasmic reticulum","volume":"103","author":"Baba","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bone.2025.117652_bb0050","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2025.117652_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2021.102501","article-title":"The Mitochondrial Ca2+ import complex is altered in ADPKD","volume":"101","author":"Yanda","year":"2022","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bone.2025.117652_bb0060","doi-asserted-by":"crossref","first-page":"17090","DOI":"10.1074\/jbc.RA119.010320","article-title":"Pharmacological reversal of renal cysts from secretion to absorption suggests a potential therapeutic strategy for managing autosomal dominant polycystic kidney disease","volume":"294","author":"Yanda","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"5575","key":"10.1016\/j.bone.2025.117652_bb0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/bmj.4.5575.331","article-title":"Total parathyroidectomy in treatment of secondary (renal) hyperparathyroidism","volume":"4","author":"Ogg","year":"1967","journal-title":"Br. Med. J."},{"issue":"7","key":"10.1016\/j.bone.2025.117652_bb0070","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1056\/NEJM197308162890710","article-title":"The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D 3, a calcium-mobilizing hormone","volume":"289","author":"DeLuca","year":"1973","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bone.2025.117652_bb0075","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2025.117652_bb0080","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.bone.2025.117652_bb0085","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"ADHR Consortium","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2025.117652_bb0090","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/872193","article-title":"Soluble \u03b1 -Klotho Serum Levels in Chronic Kidney Disease","volume":"2015","author":"Rotondi","year":"2015","journal-title":"Int. J. Endocrinol."},{"issue":"10","key":"10.1016\/j.bone.2025.117652_bb0095","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int."},{"issue":"6655","key":"10.1016\/j.bone.2025.117652_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bone.2025.117652_bb0105","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease [published correction appears in Kidney Int. 2012 Aug;82(4):498]","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.bone.2025.117652_bb0110","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164610","article-title":"Kidney glycolysis serves as a mammalian phosphate sensor that maintains phosphate homeostasis","volume":"133","author":"Zhou","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bone.2025.117652_bb0115","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1172\/JCI131190","article-title":"Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney","volume":"130","author":"Simic","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bone.2025.117652_bb0120","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1302\/2046-3758.145.BJR-2024-0227.R1","article-title":"Impact of elevated sclerostin levels on bone resorption : unravelling structural changes and mineral metabolism disruption","volume":"14","author":"Rodr\u00edguez-Ortiz","year":"2025","journal-title":"Bone Joint Res."},{"issue":"5","key":"10.1016\/j.bone.2025.117652_bb0125","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s40620-017-0410-1","article-title":"Positioning novel biologicals in CKD-mineral and bone disorders","volume":"30","author":"Tartaglione","year":"2017","journal-title":"J. Nephrol."},{"key":"10.1016\/j.bone.2025.117652_bb0130","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.bone.2025.117652_bb0135","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","article-title":"Changing bone patterns with progression of chronic kidney disease","volume":"89","author":"Dr\u00fceke","year":"2016","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.bone.2025.117652_bb0140","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.semnephrol.2014.09.006","article-title":"News on biomarkers in CKD-MBD","volume":"34","author":"Mazzaferro","year":"2014","journal-title":"Semin. Nephrol."},{"issue":"3","key":"10.1016\/j.bone.2025.117652_bb0145","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.kint.2024.11.013","article-title":"Chronic kidney disease\u2013mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference","volume":"107","author":"Ketteler","year":"2025","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.bone.2025.117652_bb0150","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/ki.2013.526","article-title":"Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease","volume":"85","author":"Spichtig","year":"2014","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.bone.2025.117652_bb0155","first-page":"1160","article-title":"Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease","volume":"82","author":"Koshikawa","year":"2012","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.bone.2025.117652_bb0160","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbagen.2009.02.005","article-title":"Klotho and aging","volume":"1790","author":"Kuro-o","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bone.2025.117652_bb0165","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2215\/CJN.09020911","article-title":"Soluble klotho and autosomal dominant polycystic kidney disease","volume":"7","author":"Pavik","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.bone.2025.117652_bb0170","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/nep.12862","article-title":"Fibroblast growth factor 23 and soluble Klotho in patients with autosomal dominant polycystic kidney disease","volume":"22","author":"Akiyama","year":"2017","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"10.1016\/j.bone.2025.117652_bb0175","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.kint.2020.07.041","article-title":"Mineral bone disease in autosomal dominant polycystic kidney disease","volume":"99","author":"Gitomer","year":"2021","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.bone.2025.117652_bb0180","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1210\/jc.2018-00123","article-title":"Hepatic Production of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease","volume":"103","author":"Bienaim\u00e9","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.bone.2025.117652_bb0185","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1681\/ASN.V11101926","article-title":"Altered expression of type II sodium\/phosphate cotransporter in polycystic kidney disease","volume":"11","author":"Vogel","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.bone.2025.117652_bb0190","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/ndt\/gfad247","article-title":"Kidney phosphate wasting predicts poor outcome in polycystic kidney disease","volume":"39","author":"Xue","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.bone.2025.117652_bb0195","doi-asserted-by":"crossref","first-page":"837","DOI":"10.5114\/aoms.2012.30834","article-title":"Calcium-phosphate metabolism parameters and erythrocyte Ca(2+) concentration in autosomal dominant polycystic kidney disease patients with normal renal function","volume":"9","author":"Pietrzak-Nowacka","year":"2013","journal-title":"Arch. Med. Sci."},{"issue":"16","key":"10.1016\/j.bone.2025.117652_bb0200","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145693","article-title":"Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression","volume":"131","author":"Shiizaki","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.bone.2025.117652_bb0205","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2215\/CJN.12821216","article-title":"Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease","volume":"12","author":"Chonchol","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"23","key":"10.1016\/j.bone.2025.117652_bb0210","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.bone.2025.117652_bb0215","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.kint.2018.09.018","article-title":"A distinct bone phenotype in ADPKD patients with end-stage renal disease","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney Int."},{"issue":"18","key":"10.1016\/j.bone.2025.117652_bb0220","article-title":"Bone health in autosomal dominant polycystic kidney disease (ADPKD) patients after kidney transplantation","volume":"11","author":"Zubidat","year":"2023","journal-title":"Bone Rep."},{"issue":"1","key":"10.1016\/j.bone.2025.117652_bb0225","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/jcb.10284","article-title":"A model for mechanotransduction in bone cells: the load-bearing mechanosomes","volume":"88","author":"Pavalko","year":"2003","journal-title":"J. Cell. Biochem."},{"issue":"21","key":"10.1016\/j.bone.2025.117652_bb0230","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.211191098","article-title":"Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene","volume":"98","author":"Boulter","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"41","key":"10.1016\/j.bone.2025.117652_bb0235","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M604772200","article-title":"Cilia-like structures and polycystin-1 in osteoblasts\/osteocytes and associated abnormalities in skeletogenesis and Runx2 expression","volume":"281","author":"Xiao","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"27","key":"10.1016\/j.bone.2025.117652_bb0240","doi-asserted-by":"crossref","first-page":"16744","DOI":"10.1074\/jbc.M114.628313","article-title":"The Wnt inhibitor sclerostin is up-regulated by mechanical unloading in osteocytes in vitro","volume":"290","author":"Spatz","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bone.2025.117652_bb0245","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ekir.2017.01.001","article-title":"SclerostinA Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?","volume":"2","author":"Jankowska","year":"2017","journal-title":"Kidney Int Rep."},{"issue":"12","key":"10.1016\/j.bone.2025.117652_bb0250","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/ckj\/sfac193","article-title":"Association between cause of kidney failure and fracture incidence in a national US dialysis population cohort study","volume":"15","author":"Ziolkowski","year":"2022","journal-title":"Clin. Kidney J."},{"issue":"9","key":"10.1016\/j.bone.2025.117652_bb0255","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1916","article-title":"Rapid cortical bone loss in patients with chronic kidney disease","volume":"28","author":"Nickolas","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2025.117652_bb0260","first-page":"317","article-title":"Fractures in chronic kidney disease: pursuing the best screening and management","volume":"24","author":"Jamal","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"5","key":"10.1016\/j.bone.2025.117652_bb0265","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40620-017-0404-z","article-title":"Osteoporosis, bone mineral density and CKD-MBD: treatment considerations","volume":"30","author":"Bover","year":"2017","journal-title":"J. Nephrol."},{"issue":"10","key":"10.1016\/j.bone.2025.117652_bb0270","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.ekir.2023.07.017","article-title":"Cardiovascular Manifestations and Management in ADPKD","volume":"8","author":"Sagar","year":"2023","journal-title":"Kidney Int Rep."},{"key":"10.1016\/j.bone.2025.117652_bb0275","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrneph.2014.49","article-title":"Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease","volume":"10","author":"Scialla","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bone.2025.117652_bb0280","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.bone.2011.01.016","article-title":"Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD)","volume":"48","author":"Manghat","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2025.117652_bb0285","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ndt\/gfr316","article-title":"FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart","volume":"27","author":"Ford","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.bone.2025.117652_bb0290","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1159\/000492244","article-title":"The Association of Fibroblast Growth Factor 23 with Arterial Stiffness and Atherosclerosis in Patients with Autosomal Dominant Polycystic Kidney Disease","volume":"43","author":"Coban","year":"2018","journal-title":"Kidney Blood Press. Res."},{"issue":"11","key":"10.1016\/j.bone.2025.117652_bb0295","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bone.2025.117652_bb0300","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jim-2016-000193","article-title":"High serum soluble \u03b1-klotho levels in patients with autosomal dominant polycystic kidney disease","volume":"65","author":"Sari","year":"2017","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.bone.2025.117652_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.632260","article-title":"An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk","volume":"12","author":"V\u00e1zquez-S\u00e1nchez","year":"2021","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.bone.2025.117652_bb0310","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000529119","article-title":"Cardiovascular Involvement in Patients with Autosomal Dominant Polycystic Kidney Disease: A Review","volume":"49","author":"Pietrzak-Nowacka","year":"2024","journal-title":"Kidney Blood Press. Res."},{"issue":"1\u20132","key":"10.1016\/j.bone.2025.117652_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-006-9355-8","article-title":"Calcium signaling phenomena in heart diseases: a perspective","volume":"298","author":"Chakraborti","year":"2007","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.bone.2025.117652_bb0320","first-page":"290","article-title":"Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease","volume":"7","author":"Helal","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"issue":"12","key":"10.1016\/j.bone.2025.117652_bb0325","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.3390\/molecules25122757","article-title":"The Off-Target Effects, Electrolyte and Mineral Disorders of SGLT2i","volume":"25","author":"Cianciolo","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bone.2025.117652_bb0330","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI72227","article-title":"Metabolic response to sodium\u2013glucose cotransporter 2 inhibition in type 2 diabetic patients","volume":"124","author":"Ferrannini","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bone.2025.117652_bb0335","first-page":"308","article-title":"Effects of dapagliflozin on circulating markers of phosphate homeostasis","volume":"30","author":"de Jong","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.bone.2025.117652_bb0340","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MNH.0000000000000632","article-title":"Tubular effects of sodium\u2013glucose cotransporter 2 inhibitors: intended and unintended consequences","volume":"29","author":"Dominguez Rieg","year":"2020","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"4","key":"10.1016\/j.bone.2025.117652_bb0345","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MNH.0000000000000505","article-title":"Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus","volume":"28","author":"Vinke","year":"2019","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bone.2025.117652_bb0350","series-title":"Kidney International KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)","author":"Torres","year":"2025"},{"issue":"12","key":"10.1016\/j.bone.2025.117652_bb0355","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-088317","article-title":"Empagliflozin in patients with autosomal dominant polycystic kidney disease (EMPA-PKD): study protocol for a randomised controlled trial","volume":"14","author":"Bahlmann-Kroll","year":"2024","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.bone.2025.117652_bb0360","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jbmr.4724","article-title":"Cardiovascular safety of romosozumab: new insights from postmenopausal women with chronic kidney disease","volume":"38","author":"Adami","year":"2023","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2025.117652_bb0365","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/ndt\/gfac298","article-title":"Tolvaptan treatment is associated with altered mineral metabolism parameters and increased bone mineral density in ADPKD patients","volume":"38","author":"Bargagli","year":"2023","journal-title":"Nephrol. Dial. Transplant."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328225002649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328225002649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:00:29Z","timestamp":1780300829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328225002649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":73,"alternative-id":["S8756328225002649"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2025.117652","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic kidney disease- mineral and bone disorder in autosomal dominant policystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2025.117652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117652"}}